ArticleFrontiers in oncology2025
Amide proton transfer-weighted imaging and T1 mapping as diagnostic tools to evaluate high-risk histopathologic phenotypes before surgery in rectal adenocarcinoma and their correlation with Ki-67 expression:a two-center study.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To investigate the application of amide proton transfer (APT)-weighted MRI, T1 mapping in evaluating the preoperative high-risk histopathologic phenotypes of rectal adenocarcinoma and their correlation with Ki-67 expression. Materials and Methods: Retrospective collection of 178 confirmed cases of rectal adenocarcinoma from two centers (center 1: 97 cases, center 2: 81 cases). High-resolution T2WI, APT, T1 mapping, diffusion-weighted imaging (DWI), and Ki-67 staining were performed in all patients. The measured parameters included APT signal intensity (APT SI), T1 relaxation time before (native T1) and after (post-contrast T1) enhancement, and apparent diffusion coefficient (ADC). The receiver operating characteristic (ROC) curve was used to evaluate diagnostic efficiency, and Spearman correlation analysis was used to evaluate the correlation between parameters with Ki-67, respectively. Results: APT SI values were significantly different between the mucinous adenocarcinoma (MC) group and the common adenocarcinoma (AC) group in two centers (center 1: [2.64 ± 0.33%] vs. [2.22 ± 0.78%], Conclusion: APT and T1 mapping can be used to evaluate the preoperative pathological classification, TN staging, and structural invasion of rectal adenocarcinoma, which has the potential to become an imaging marker for the evaluation of high-risk histopathologic phenotypes and Ki-67 expression of rectal adenocarcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.